Brief: Lansen Pharmaceutical Holdings Says Liu Bangmin Resigned As CEO
29/01/2018 04:06
Jan 29 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* LIU BANGMIN RESIGNED AS EXECUTIVE DIRECTOR AND CHIEF
EXECUTIVE
OFFICER
Source text for Eikon: ID:nHKS6D7Fxg
Further company coverage: 0503.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year